Inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme in the de novo synthesis of guanine nucleotides, is a therapeutic target for anticancer and antiviral agents. Among the 15 different polyphenols examined, curcumin was found to have an inhibitory effect on the IMPDH activity in both a competitive and uncompetitive manner and to suppress the cellular GTP level in HT-29 colon carcinoma cells.
The enzyme, inosine monophosphate dehydrogenase (IMPDH), catalyzes the nicotinamide adenine dinucleotide (NAD þ )-dependent oxidation of inosine monophosphate (IMP) to xanthine monophosphate (XMP) in de novo synthesis. 1) This enzyme is a critical determinant of the level of guanine nucleotides, including guanosine triphosphate (GTP) , that are essential for many cellular functions. 2) Inhibitors of IMPDH are sought as potential pharmacological anticancer and antiviral agents. 3, 4) The consumption of polyphenolic compounds is believed to suppress the development of cancer through mechanisms including reducing the inflammatory process, and hyperproliferation. 5) We examined in the present study the influence of various polyphenols on the activity of IMPDH.
IMP and NAD þ were purchased from Sigma Aldrich (St. Louis, MO, USA), and curcumin, resveratrol, genistein, eugenol, gingerol, chlorogenic acid, epigallocatechin gallate, naringenin, naringin and caffeic acid were purchased from Nacalai Tesque (Kyoto, Japan). Morin, kaempferol, hesperidin and ellagic acid were purchased from Wako Pure Chemicals (Osaka, Japan) and rosmarinic acid was purchased from MP Biomedicals (Ohio, USA).
The cloning of mouse IMPDH type II and isolation of recombinant mouse IMPDH were conducted according to our previous report.
1) The assay procedure for IMPDH was described in the same report, 1) in which various polyphenols were added to the assay mixture by dissolving in 10% dimethyl sulfoxide at 1 mM. Colon carcinoma cell line HT-29 cells were maintained in Dulbecco's modified Eagle's medium (Sigma Aldrich, St. Louis, MO, USA) supplemented with 10% fetal calf serum, 100 units/ml of penicillin, and 100 mg/ml of streptomycin at 37 C in 5% CO 2 . A cell suspension (3 Â 10 3 cells/ml) was cultured for 48 h, and then the medium was replaced with a culture medium containing curcumin. After 72 h, the cell growth was evaluated by an MTT assay.
6) The cellular GTP levels were determined by an HPLC analysis according to the method reported. 7) All data are expressed as the mean AE SE, and all were analyzed by Scheffe's multiple-range test (Excel Statistics 2006 for Windows, Social Survey Research Information Co., Tokyo, Japan). Results are considered significant with a value of p < 0:05.
We investigated the inhibition of IMPDH by various polyphenols. As shown in Fig. 1 , among the polyphenols examined, curcumin (68% inhibition), epigallocatechin gallate (47% inhibition), chlorogenic acid (30% inhibition) and ellagic acid (27% inhibition) effectively inhibited the activity of IMPDH at a concentration of 100 mM. Resveratrol, genistein, eugenol, gingerol, naringenin, naringin, caffeic acid, morin, kaempferol, hesperidin and rosmarinic acid had no effect on the activity of IMPDH (data not shown). The dosedependent inhibition by curcumin was observed at concentrations of 0-200 mM with an IC 50 value of 43.0 mM, at least 20 mM being necessary for significant inhibition. The IC 50 values for epigallocatechin gallate, chlorogenic acid and ellagic acid were 112.5 mM, >200 mM and >200 mM, respectively.
To obtain further information for the inhibition of IMPDH by curcumin, the extent of inhibition as a function of the IMP substrate concentration was studied (Fig. 2) . A Lineweaver-Burk plot indicated that the Km value remained unchanged by different concentrations of curcumin, while Vmax increased with increasing curcumin concentration (0, 50, 75, and 100 mM). The results were Km ¼ 50:9 mM and Vmax ¼ 0:063 mmoles/min/ml. The Ki value was determined to be 99.7 mM (data not shown). These plots suggest the manner of inhibition to be both competitive and uncompetitive. This is similar to such well-known competitive and uncompetitive IMPDH inhibitors as mycophenolate mofetil, mizoribine and ribavirin with respect to IMP. 8) To elucidate in detail the interaction between IMPDH and curcumin, it will be necessary to examine the X-ray crystal and NMR analyses of the complex of IMPDH and curcumin.
To examine the effect of curcumin on the GTP level in colon cancer cells, HT-29 cells were treated with curcumin at 50, 75, and 100 mM concentrations for 48 h (Fig. 3 ). Curcumin significantly reduced the level of GTP at the concentrations of 75 and 100 mM, implying a suppressive effect of curcumin on the GTP pool. IMPDH inhibition results in a depletion of the guanine y To whom correspondence should be addressed. Fax: +81-82-424-7916; E-mail: nkato@hiroshima-u.ac.jp Biosci. Biotechnol. Biochem., 74 (1), [185] [186] [187] 2010 Note nucleotide pool, with subsequent decreased DNA and RNA synthesis. 9) Increased IMPDH activity is correlated with increased cellular proliferation and transformation. 1) In our MTT assay, the relative values of cell growth (%) at 0, 50, 75, and 100 mM of curcumin (n ¼ 5) were 100 AE 1, 31:6 AE 0:3, 26:2 AE 0:4, and 17:0 AE 0:2, respectively (curcumin effect at 50-100 mM, p < 0:05). These results indicate that 50 mM curcumin had no effect on cellular GTP, but significantly suppressed the cell growth. Thus, the reduction in cell growth by higher curcumin levels (75 and 100 mM) appears to be associated with the reduced GTP level. Curcumin, epigallocatechin gallate, chlorogenic acid and ellagic acid, which were found to inhibit IMPDH activity in this study, have been reported to possess anticancer activity via cell proliferation inhibition [10] [11] [12] [13] and antiviral activity. [14] [15] [16] [17] We speculate that the anticancer and antiviral mechanisms of these polyphenols might be, at least in part, mediated by some inhibition of IMPDH. Further study is necessary to test this possibility.
It has been reported for mice fed on a 0.2% curcumincontaining diet that the steady-state levels of intact curcumin were 111 mM in the small intestinal mucosa and 508 mM in the colonic mucosa, although the serum level was 5 nM.
18) The dose of curcumin in humans corresponding to a dietary 0.2% curcumin level used in mice is 1.6 g/d, when calculated on the basis of a body surface area of 1.8 m 2 accompanying a body weight of 70 kg in humans. 18, 19) This is close to a putative efficacious clinical dose of curcumin of 1.2-1.8 g/d in humans. 20) Thus, the curcumin level achieved in the intestinal tract by an oral administration appears to be enough to inhibit the IMPDH activity, but not enough to affect the serum level. The concentration of polyphenols examined was 100 mM. The enzyme activity in the absence of polyphenols was taken as 100%. Each value is the mean AE SE, n ¼ 4{6.
Ã Significantly different from the control value (p < 0:05).
In summary, the results of this study provide the first evidence for the inhibitory effect of curcumin on the activity of IMPDH, the target for anticancer and antiviral agents. This finding implies a novel function for a polyphenol that is favorable to health.
